See Event Calendar Donate

Baltics (Associate)

PARTNERS

PARTICIPANTS FROM INSTITUTIONS

REGIONAL LEADERSHIP

Laima Šusta

Laima Šusta
Co-MD (Baltics)
Alīna Reķēna
Co-MD (Baltics)
Signe Parts
Communications Director (Baltics)
Karl-Ander Kasuk
Advisor/ex Co-MD (Baltics)
Lauren Elisabeth Lind
Co-MD (Estonia)
Carl-Christjan Bogoslovski
Co-MD (Estonia)
Gerda Schotter
Events Lead (Genesis) (Estonia)
Daniela Godiņa
Co-MD (Latvia)
Liucija Vaicenavičiūtė
Co-MD (Lithuania)
Sandra Kmitaitė
Co-MD (Lithuania)
Margaret Pütsepp
Partnerships Lead
Klaus Martin Klettenberg
Events Lead
Anna Elizabeta Strazda
Communications Lead
Emilija Zuokaite
Communications Lead

<br /> — Laima Šusta
Co-MD (Baltics)

<br /> — Alīna Reķēna
Co-MD (Baltics)

<br /> — Signe Parts
Communications Director (Baltics)

<br /> — Karl-Ander Kasuk
Advisor/ex Co-MD (Baltics)

<br /> — Lauren Elisabeth Lind
Co-MD (Estonia)

<br /> — Carl-Christjan Bogoslovski
Co-MD (Estonia)

<br /> — Gerda Schotter
Events Lead (Genesis) (Estonia)

<br /> — Daniela Godiņa
Co-MD (Latvia)

<br /> — Liucija Vaicenavičiūtė
Co-MD (Lithuania)

<br /> — Sandra Kmitaitė
Co-MD (Lithuania)

<br /> — Margaret Pütsepp
Partnerships Lead

<br /> — Klaus Martin Klettenberg
Events Lead

<br /> — Anna Elizabeta Strazda
Communications Lead

<br /> — Emilija Zuokaite
Communications Lead

Apply for
Activator

2024 COHORT

Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.

Deadline for US chapters is October 21st. Deadline for international chapters will vary. Please contact your local chapter to verify.

REQUIREMENTS

01

Approval from PI
02

Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
03

Existing IP to protect the technology, or clear path to file IP within the next year
04

Clear potential to apply the technology
05

Team intending and willing to 'spin-out' in the near future